
|Videos|October 11, 2016
Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
Advertisement
Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
4
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
5